LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH AUTOINFLAMMATORY PERIODIC FEVER SYNDROMES - FIRST INTERIM ANALYSIS OF THE FMF/TRAPS/HIDS SUBGROUPS FROM THE RELIANCE REGISTRY

被引：0
|
作者：
Henes, J. [1 ]
Kuemmerle-Deschner, J. B. [1 ]
Borte, M. [2 ]
Foeldvari, I.
Horneff, G. [3 ]
Kallinich, T. [4 ]
Kortus-Goetze, B. [5 ]
Weller-Heinemann, F. [6 ]
Weber-Arden, J. [7 ]
Blank, N. [8 ]
机构：
[1] Univ Hosp, Tubingen, Germany
[2] Hosp St Georg, Leipzig, Germany
[3] Asklepios Clin, St Augustin, Germany
[4] Charite, Berlin, Germany
[5] Univ Hosp, Marburg, Germany
[6] Prof Hess Kinderklin, Bremen, Germany
[7] Novartis, Nurnberg, Germany
[8] Univ Hosp, Heidelberg, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.5878
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0486
引用
收藏
页码：837 / 837
页数：1
相关论文
共 50 条
  • [21] No Cumulative Effect of Infection Rates in Children Receiving Long-term Canakinumab Treatment in Autoinflammatory Periodic Fever Syndromes - Data from the RELIANCE Registry
    Kuemmerle-Deschner, Jasmin B.
    Henes, Joerg
    Kortus-Goetze, Birgit
    Oommen, Prasad T.
    Pankow, Anne
    Kallinich, Tilmann
    Krickau, Tobias
    Schuetz, Catharina
    Horneff, Gerd
    Foeldvari, Ivan
    Rech, Juergen
    Weller-Heinemann, Frank
    Janda, Ales
    Hufnagel, Markus
    Meier, Florian M.
    Dressler, Frank
    Borte, Michael
    Andreica, Ioana
    Wasiliew, Peter
    Fiene, Michael
    Windschall, Daniel
    Krusche, Martin
    Kuempfel, Tania
    Weber-Arden, Julia
    Blank, Norbert
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 536 - 538
  • [22] Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD AND TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial
    De Benedetti, Fabrizio
    Anton, Jordi
    Ben-Chetrit, Eldad
    Calvo, Inmaculada
    Frenkel, Joost
    Gattorno, Marco
    Hoffman, Hal M.
    Kasapcopur, Ozgur
    Kone-Paut, Isabelle
    Lachmann, Helen
    Moutschen, Michel
    Ozen, Seza
    Quartier, Pierre
    Simon, Anna
    Zeft, Andrew
    Lheritier, Karine
    Speziale, Antonio
    Junge, Guido
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [23] Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients with Cryopyrin-associated Periodic Syndromes (CAPS)-30-months Interim Analysis of the RELIANCE Registry
    Kuemmerle-Deschner, Jasmin
    Kortus-Goetze, Birgit
    Oommen, Prasad T.
    Janda, Ales
    Rech, Juergen
    Kallinich, Tilmann
    Weller-Heinemann, Frank
    Horneff, Gerd
    Foeldvari, Ivan
    Schuetz, Catharina
    Borte, Michael
    Braner, Axel
    Weber-Arden, Julia
    Blank, Norbert
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 381 - 382
  • [24] Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial
    De Benedetti, Fabrizio
    Anton, Jordi
    Ben-Chetrit, Eldad
    Calvo, Inmaculada
    Frenkel, Joost
    Gattorno, Marco
    Hoffman, Hal M.
    Kasapcopur, Ozgur
    Kone-Paut, Isabelle
    Lachmann, Helen
    Moutschen, Michel
    Ozen, Seza
    Quartier, Pierre
    Simon, Anna
    Zeft, Andrew
    Lheritier, Karine
    Speziale, Antonio
    Junge, Guido
    ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 22 - 23
  • [25] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN FAMILIAL MEDITERRANEAN FEVER (FMF)-36-MONTH DATA FROM THE RELIANCE REGISTRY
    Henes, J.
    Blank, N.
    Krickau, T.
    Pankow, A.
    Foeldvari, I.
    Dressler, F.
    Horneff, G.
    Kallinich, T.
    Oommen, P.
    Meier, F.
    Weller-Heinemann, F.
    Kortus-Goetze, B.
    Hufnagel, M.
    Rech, J.
    Andreica, I.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1160 - 1161
  • [26] LONG-TERM EFFECTIVENESS OF CANAKINUMAB IN AID - INTERIM ANALYSIS OF THE CAPS SUBGROUP FROM THE RELIANCE REGISTRY
    Blank, N.
    Borte, M.
    Foeldvari, I.
    Horneff, G.
    Kallinich, T.
    Kortus-Goetze, B.
    Oommen, P.
    Schuetz, C.
    Weller-Heinemann, F.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1207 - 1207
  • [27] Long-Term Efficacy and Safety of Canakinumab in Patients with Colchicine-Resistant FMF (crFMF), Hids/Mkd and TRAPS: Results from the Pivotal Phase 3 Cluster Trial
    De Benedetti, Fabrizio
    Frenkel, Joost
    Simon, Anna
    Anton, Jordi
    Lachmann, Helen J.
    Gattorno, Marco
    Ozen, Seza
    Kone-Paut, Isabelle
    Ben-Chetrit, Eldad
    Wozniak, Magdalena
    Wei, Xiaoling
    Vritzali, Eleni
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [28] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH COLCHICINE-RESISTANT FMF (CRFMF), TRAPS AND HIDS/MKD: RESULTS FROM THE PIVOTAL PHASE 3 CLUSTER TRIAL
    De Benedetti, F.
    Frenkel, J.
    Simon, A.
    Anton, J.
    Lachmann, H.
    Gattorno, M.
    Ozen, S.
    Kone-Paut, I.
    Ben-Chetrit, E.
    Wozniak, M. B.
    Wang, J. G.
    Vritzali, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 486 - 487
  • [29] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES-36-MONTH DATA FROM THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Kortus-Goetze, B.
    Oommen, P.
    Janda, A.
    Rech, J.
    Schuetz, C.
    Kallinich, T.
    Weller-Heinemann, F.
    Horneff, G.
    Foeldvari, I.
    Meier, F.
    Borte, M.
    Krickau, T.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 346 - 347
  • [30] LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-4-YEARS DATA FROM THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Kortus-Goetze, B.
    Schuetz, C.
    Oommen, P.
    Janda, A.
    Rech, J.
    Weller-Heinemann, F.
    Kallinich, T.
    Pankow, A.
    Horneff, G.
    Foeldvari, I.
    Wasiliew, P.
    Borte, M.
    Fiene, M.
    Meier, F.
    Krickau, T.
    Andreica, I.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 167 - 167
12345